Program
PRAX-628
A development code. Also written as “20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks” and “30mg PRAX-628”.
Its studies are mostly in Seizures, led by Praxis Precision Medicines.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Praxis Precision Medicines | 31 open or running | phase 3since Mar 14, 2025 | Jan 29, 2025 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jan 29, 2025First study: phase 1 study in HealthyFirst studyNCT06840925 · 16 enrolled · Australia
- Mar 14, 2025Phase 3 study in SeizuresNCT06999902 · 255 enrolled · United States, Brazil, Canada and more
- Mar 19, 2025Phase 2 study in SeizuresNCT06908356 · 50 planned · United States, Australia, Spain
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06908356Seizures · United States, Australia, Spain | 2 | Recruiting | Jul 2025 | 50 |
| NCT06999902Seizures · United States, Brazil, Canada and more | 3 | Completed | May 14, 2026 | 255 |
| NCT06840925Healthy · Australia | 1 | Completed | Jun 5, 2025 | 16 |
How it is read
Names in the registry
- “20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks”, 2 entries
- “PRAX-628”, 1 entry
- “30mg PRAX-628”, 1 entry
Codes read as this program: PRAX628.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.